Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national
5
×
national blog main
national top stories
biotech
clinical trials
fda
new york blog main
new york top stories
san francisco top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
genentech
indiana blog main
indiana top stories
merck
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
biohaven
bristol-myers squibb
cancer
celgene
drugs
eli lilly
pfizer
roche
What
approved
5
×
drug
fda
new
bio
medicine
news
roundup
treatment
adu
adults
allergan
atrophy
beats
bids
biogen
cancer
class
companies
complicated
daily
deeper
depression
digital
dire
disease
dna
epidemic
evrysdi
fatty
fingerprint
frenzied
friday
genetic
going
good
green
group
growing
heart
Language
unset
Current search:
approved
×
national
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues